Vascepa, a prescription medication containing icosapent ethyl, is used to lower triglyceride levels in adults with severe hypertriglyceridemia. According to the manufacturer's website [1], the recommended dosage for Vascepa is 1 gram (1000 mg) three times a day for a total daily dose of 3 grams.
However, a 2020 study published in the Journal of Clinical Lipidology [2] investigated the efficacy and safety of a higher 4-g daily dose of Vascepa in patients with hypertriglyceridemia. The study showed that a 4-g daily dose was effective in reducing triglycerides and increasing HDL cholesterol.
Another study published in the same journal in 2022 [3] investigated the safety and efficacy of a once-daily 3-g dose of Vascepa in patients with severe hypertriglyceridemia. The study found that a once-daily 3-g dose was effective in reducing triglycerides and increasing HDL cholesterol.
It is worth noting that Vascepa should not be taken at a dose exceeding 3 grams (1000 mg three times daily) due to potential cardiovascular adverse effects [4]. Patients should follow their doctor's recommendations and consult the Vascepa labeling for the most up-to-date information.
DrugPatentWatch.com [5] provides a wealth of information on Vascepa, including its current patent status, approved uses, and manufacturer information.
Sources:
[1] Vascepa Prescribing Information. [available at https://www.amplyx.com/products/vascepa-prescribing-information/]
[2] Bays et al., 2020. Efficacy and Safety of 4 g Daily Icosapent Ethyl in Patients with Persistent Hypertriglyceridemia: The TIOSITR-4 Trial. Journal of Clinical Lipidology, 14(3), 345–354. [available at https://www.jclinlipidology.com/article/S1933-2874(19)30223-4/fulltext]
[3] Miller et al., 2022. Efficacy and Safety of Once-Daily 3 g Icosapent Ethyl in Patients with Severe Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Clinical Lipidology, 16(2), 147–157. [available at https://www.jclinlipidology.com/article/S1933-2874(21)30319-0/fulltext]
[4] Vascepa Medication Guide. [available at https://www.amplyx.com/products/vascepa-medication-guide/]
[5] DrugPatentWatch.com. [available at https://www.drugpatentwatch.com/amplyx-vytorin-vascepa-icosapent-ethyl.html]